Clinical Trials
5 trialsNCT07469774 2026-05-28
BC3195 in Combination With Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
Biocity Biopharmaceutics Co., Ltd.
Phase 1/2 Recruiting
NCT07607054 2026-05-26
A First-in-human Phase I Study to Evaluate EMB-15 in Patients With Locally Advanced or Metastatic Solid Tumors.
Shanghai EpimAb Biotherapeutics Co., Ltd.
Phase 1 Not yet recruiting
NCT06307795 2026-04-17
A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid Tumors
Avistone Biotechnology Co., Ltd.
Phase 1 Recruiting
NCT06328439 2026-03-25
A Study to Evaluate ANS014004 in Subjects With Locally Advanced or Metastatic Solid Tumors
Avistone Biotechnology Co., Ltd.
Phase 1 Active not recruiting
NCT07461181 2026-03-10
A Study to Evaluate the Safety, Tolerability, PK, PD, and Preliminary Efficacy of CS01 in Patients With Locally Advanced or Metastatic Solid Tumors
Ruijin Hospital
Phase 1/2 Active not recruiting